DIRS.INFO The most relevant business & tech news

☆ Watch CNBC's full interview with Glenview Capital Management CEO Larry Robbins
▼ + stars: | 2024-11-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC's full interview with Glenview Capital Management CEO Larry RobbinsLarry Robbins, Glenview Capital Management CEO, joins CNBC's 'Squawk on the Street' to discuss his firm's four new seats on the board at CVS, how the company can recover after a long decline, and more.

Persons: Larry Robbins Larry Robbins Organizations: Glenview Capital, Glenview Capital Management, CVS

☆ Glenview Capital CEO Larry Robbins on the deal for new CVS Health board seats
▼ + stars: | 2024-11-18 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGlenview Capital CEO Larry Robbins on the deal for new CVS Health board seatsLarry Robbins, Glenview Capital Management CEO, joins CNBC's 'Squawk on the Street' to discuss his firm's four new seats on the board at CVS, how the company can recover after a long decline, and more.

Persons: Larry Robbins Organizations: Glenview, CVS Health, Glenview Capital Management, CVS

☆ CVS strikes deal with activist Glenview Capital for four board seats
▼ + stars: | 2024-11-18 | by ( Rohan Goswami | In Rohangoswamicnbc | ) www.cnbc.com time to read: +1 min

CVS Health announced on Monday that it struck a deal with dissident investor Glenview Capital for four board seats, just a few weeks after the healthcare giant ousted former chief Karen Lynch. Glenview CEO Larry Robbins will join the CVS board effective immediately, alongside three other directors, which CVS said emerged from a "productive discussion" with Glenview. CVS' board will expand to 16 members. Glenview amassed a sizable stake in the healthcare conglomerate and worked with management in the lead-up to Lynch's ouster. Elliott Management struck a deal with Southwest Airlines in October in which the activist fund secured six seats on the carrier's board.

Persons: David Joyner, Karen Lynch, Larry Robbins, Roger Farah, Leslie Norwalk, Guy Sansone, Doug Schulman, Glenview's Robbins, Ancora, Alan Shaw Organizations: CVS, Health, Education, Labor, Washington , D.C, CVS Health, Glenview Capital, Glenview, Elliott Management, Southwest Airlines, Norfolk Locations: Washington ,, Glenview, Norfolk Southern

☆ Stocks making the biggest moves midday: Moderna, Roku, CVS Health, Robinhood and more
▼ + stars: | 2024-11-18 | by ( Brian Evans | ) www.cnbc.com time to read: +3 min

Trump Media & Technology Group — Shares in President-elect Donald Trump's media company pulled back roughly 5%. Although the stock has been increasingly volatile in the wake of Trump's election, it has gained more than 52% in 2024. Redfin — The online real estate company's stock slipped 3.4% following a downgrade at Goldman Sachs to sell from neutral. CVS Health — Shares of the drugstore operator jumped nearly 6% following a decision to add four new board members in a deal with Glenview Capital. Moderna — Shares of the biotech company jumped more than 5% after HSBC upgraded the stock to buy from hold and said it views the stock as being undervalued.

Persons: Donald Trump's, Donald Trump, Chris Wright, Wright, Baird, Goldman Sachs, Wells, Needham, Piper Sandler, —, Alex Harring, Sean Conlon, Hakyung Kim, Pia Singh, Michelle Fox Organizations: Spirit Airlines —, Trump Media & Technology, Liberty Energy, Goldman, CVS, Glenview Capital, Aetna, U.S . Securities, Exchange, Nasdaq, Moderna —, HSBC, Warner Bros, —, National Basketball Association Locations: Wells Fargo

☆ CVS replaces CEO as profits, share price suffer
▼ + stars: | 2024-10-18 | by ( Jacob Pramuk | Sara Salinas | ) www.nbcnews.com time to read: +2 min

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. CVS has faced challenges as higher medical costs weigh on its insurance unit, Aetna, and consumer spending drops at its retail pharmacies. It anticipates higher medical costs than previously expected, with a so-called medical benefit ratio of 95.2% in the quarter. CNBC reported last month that CVS’ board had engaged strategic advisors to weigh its options, including the potential of a breakup of its insurance and retail businesses. Lynch also stepped down from the company’s board of directors this week, the company said Friday.

Persons: David Joyner, Karen Lynch, CVS, ” CVS, Joyner, Lynch, “, David, Roger Farah, Farah Organizations: CVS, Aetna, Glenview Capital, CNBC, CVS Health

☆ CVS is under pressure and considering a breakup. Here's why that could be risky
▼ + stars: | 2024-10-04 | by ( Annika Kim Constantino | Annika Kim Constantino Covers The Biotech | Pharmaceutical Industry For Cnbc Digital. | ) www.nbcnews.com time to read: +13 min

It’s time for a wellness check at CVS Health. But Caremark, in some cases, also funnels drug prescriptions to CVS retail pharmacies, he said. He said a spinoff of CVS’ retail pharmacies would be more likely. A general view shows a sign of CVS Health Customer Support Center in CVS headquarters of CVS Health Corp in Woonsocket, Rhode Island, U.S. October 30, 2023. Those actions will help the company achieve its target of 100- to 200-basis-points margin improvement in its Medicare Advantage business, CVS executives said in August.

Persons: Caremark, ”, eMarketer, Rajiv Leventhal, Karen Lynch, Lynch, Brian Kane, “, ” Jefferies, Brian Tanquilut, Elizabeth Anderson, Anderson, it’s, eMarketer’s Leventhal, ” Tanquilut, Ann Hynes, Tanquilut, “ they’re, they’re, Michael Cherny, Cherny, Faith Ninivaggi, Reuters Cherny, CVS, Tom Cowhey Organizations: CVS Health, CVS, CNBC, Aetna, Monday, Glenview Capital, Glenview, Evercore ISI, UnitedHealth, Humana, Walgreens, Street Health, Oak, Health, Mizuho, Amazon, Walmart, Oak Street, Leerink Partners, Affordable, Medicare, CVS Health Corp, Reuters, Centers, Medicaid Services Locations: U.S, Caremark, Aetna, Texas and Illinois, Woonsocket , Rhode Island

☆ CVS is under pressure and considering a break up. Here's why that could be risky
▼ + stars: | 2024-10-04 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +11 min

In this article CVS Follow your favorite stocks CREATE FREE ACCOUNTA sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. That means Caremark also sits at the intersection of CVS' retail pharmacy operation and its Aetna insurer, boosting the competitive advantage of both of the businesses. A workers stocks the shelves in a CVS pharmacy store on February 07, 2024 in Miami, Florida. An Oak Street Health clinic stands in a Brooklyn neighborhood on February 08, 2023 in New York City. A general view shows a sign of CVS Health Customer Support Center in CVS headquarters of CVS Health Corp in Woonsocket, Rhode Island, U.S. October 30, 2023.

Persons: Joe Raedle, Caremark, Rajiv Leventhal, Karen Lynch, Lynch, Brian Kane, Jefferies, Brian Tanquilut, Elizabeth Anderson, Anderson, it's, eMarketer's Leventhal, Tanquilut, Ann Hynes, Spencer Platt, they're, Michael Cherny, Cherny, Faith Ninivaggi Organizations: Getty, CVS Health, CVS, CNBC, Aetna, Monday, Glenview Capital, Glenview, UnitedHealth, Humana, Walgreens, Street Health, Oak, Health, Mizuho, Oak Street Health, Amazon, Walmart, Oak Street, Leerink Partners, Affordable, Medicare, CVS Health Corp Locations: Miami , Florida, U.S, Aetna, Caremark, Brooklyn, New York City, Texas and Illinois, Woonsocket , Rhode Island

☆ Stocks making the biggest moves midday: EchoStar, CVS Health, Stellantis and more
▼ + stars: | 2024-09-30 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +2 min

Check out the companies making headlines in midday trading: Nio — The U.S.-listed shares of the Chinese electric vehicle maker climbed 9.5% after Nio announced a 13.3 billion yuan cash injection for its Nio China business. The transactions are expected to be completed by year-end, and will reduce Nio Inc.'s stake in Nio China to 88.3% from its current 92.1%. CVS Health — Shares jumped 3.3% on news that hedge fund Glenview Capital intends to meet with CVS Health's executives to boost the struggling business. Crypto stocks — Stocks tied to the price of bitcoin retreated with the cryptocurrency following a sizeable rally last week. Cumberland Hospital for Children and Adolescents is an "indirect subsidiary" of Universal Health Services, according to an 8-K filing.

Persons: Nio, Alibaba, Stocks, bitcoin, Coinbase, MicroStrategy, Bitcoin, EchoStar, Piper Sandler, Stephen Scouten, — CNBC's Sean Conlon, Tanaya Macheel, Sarah Min, Jesse Pound, Pia Singh Organizations: Nio Inc, GM, Ford, CVS, —, Glenview Capital, CNBC, DirecTV, Amerant, Moderna, Universal Health Services, Cumberland Hospital for Children Locations: U.S, China, Glenview, Florida

☆ Stocks making the biggest moves premarket: Nio, Stellantis, MicroStrategy and more
▼ + stars: | 2024-09-30 | by ( Sean Conlon | ) www.cnbc.com time to read: +2 min

Nio – U.S.-listed shares surged more than 13% after the Chinese electric vehicle maker announced it will receive a cash injection of 13.3 billion yuan for its Nio China. "Strategic investors" will provide 3.3 billion yuan of that injection, with the rest coming from Nio Inc. The transactions, which are expected to be completed by the end of this year, will reduce Nio Inc.'s stake in Nio China to 88.3%, down from 92.1%. This also spurred a broader rally among China stocks, which saw their best day of trading since 2008 . Rocket Lab – Shares rose more than 3%, extending the more than 12% gains seen during Friday's session.

Persons: Nio, Ford, Alibaba, Stocks, bitcoin, Coinbase, MicroStrategy, Bitcoin, —, Lisa Kailai Han, Sarah Min, Tanaya Macheel Organizations: Nio Inc, KeyBanc, CVS, Street Journal, Glenview Capital Locations: Nio –, China, Glenview, East, Gulf Coast

Glenview Capital, a major CVS Health shareholder, is expected to meet with company leadership on Monday to lay out proposed fixes for the struggling business, according to people familiar with the matter, a potential precursor to an activist push. A CVS spokesperson said the company "maintains a regular dialogue with the investment community as part of our robust shareholder and analyst engagement program." Jeff Smith's Starboard Value also built a stake in the company in 2019, and engaged in discussion with the company's leadership as well. The company's insurance unit includes plans by Aetna for the Affordable Care Act, Medicare Advantage and Medicaid, along with dental and vision. In its second-quarter results in August, CVS announced a leadership shakeup based on the performance and outlook of its insurance unit.

Persons: Karen Lynch, Scott Ferguson, Jeff Smith's, Lynch, Brian Kane Organizations: Glenview, CVS Health, CVS, Teva Pharmaceuticals, Street Journal, Sachem, Capital Management, Aetna, American Medical Association, Affordable, Medicare Locations: Florida Keys, United States, Centene, Glenview

☆ CVS is working with advisors on strategic review, sources say
▼ + stars: | 2024-09-30 | by ( Rohan Goswami | In Rohangoswamicnbc | ) www.cnbc.com time to read: +1 min

CVS Health 's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter, as the company contends with potential activist pressure and a severely depressed stock price. The review has been ongoing for some time, said the people, but there is no certainty on what actions, if any, the company will take. CVS management, including CEO Karen Lynch, met with major shareholder Glenview Capital Monday to discuss the company's lagging prospects and Glenview's plans to revive the stock, CNBC previously reported. In a statement, CVS spokesman David Whitrap told CNBC: "CVS Health's management team and Board of Directors are continually exploring ways to create shareholder value. CVS shares rose around 2.5% in after-hours trading Monday on the news, which was first reported by Reuters.

Persons: Karen Lynch, Lynch, David Whitrap, Brian Kane, —, Bertha Coombs Organizations: Washington DC, CVS, Glenview Capital, CNBC, Reuters Locations: Washington, United States

☆ Arrowstreet, Coatue Management among big hedge funds buying Meta in first quarter
▼ + stars: | 2023-05-15 | by ( David Randall | ) www.reuters.com time to read: +1 min

NEW YORK, May 15 (Reuters) - Prominent hedge funds including Arrowstreet Capital LLC, D1 Capital Partners and Coatue Management LLC were among the investors that bought shares of Meta Platforms Inc in the first quarter of the year, amid an eye-popping rebound in the Facebook-parent’s stock. Arrowstreet Capital added about 5 million shares during the quarter, brining its total position to slightly more than 7 million shares, while Coatue more than doubled its position in the company by buying 4.2 million shares. Winslow Capital Management, meanwhile, initiated a new position in the firm by buying about 927,000 shares, and D1 Capital Partners bought slightly more than 1 million shares. Norges Bank, the central bank of Norway, was the largest seller among all firms, unloading more than 35 million shares during the quarter. Two Sigma Investments sold its entire stake of about 569,000 shares, while Glenview Capital Management, run by billionaire Larry Robbins, sold its entire stake of about 526,000 shares, according to filings.

Search resuls for: "Glenview Capital"

12 mentions found